HUTCHMED (CHINA) LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 314 GBX | +1.95% |
|
+4.67% | +10.95% |
| Apr. 26 | EU Panel Backs Approval of Takeda’s Colorectal Cancer Drug | MT |
| Apr. 26 | Hutchmed notes CHMP's positive opinion for fruiquintinib approval | AN |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Neutral |
| Resistance | 310.00 | 322.00 | 321.00 |
| Spread/Res. | +1.29% | -2.48% | -2.18% |
| Spread/Supp. | +10.95% | +63.20% | +80.88% |
| Support | 283.00 | 192.40 | 173.60 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- HCM Stock
- Charts HUTCHMED (China) Limited